| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/15/2011 | WO2011111908A1 Apparatus selectively collecting and recovering fine particles |
| 09/15/2011 | WO2011111876A1 Clearing reagent for biological material, and use thereof |
| 09/15/2011 | WO2011111868A1 Method for measuring cross-link density of object to be tested, method for setting conditions of cross-link density of object to be tested, lamination method for laminated product, device for measuring cross-link density of object to be tested, and device for adjusting cross-link density of object to be tested |
| 09/15/2011 | WO2011111820A1 Diagnostic marker for lung cancer or cervical cancer |
| 09/15/2011 | WO2011111790A1 Production of enteritis evoking causal factor by highly pathogenic oral bacteria and high sensitivity detection method therefor |
| 09/15/2011 | WO2011111764A1 Storage sensor substrate, dried sensor substrate, method for producing storage sensor substrate, and method for producing dried sensor substrate |
| 09/15/2011 | WO2011111715A1 Nucleic acid capable of regulating cell cycle |
| 09/15/2011 | WO2011111698A1 MONOCLONAL ANTIBODY AGAINST NECROSIS MARKER ERp29 AND USE THEREOF |
| 09/15/2011 | WO2011111694A1 Monoclonal antibody against necrosis marker prdx4 and use thereof |
| 09/15/2011 | WO2011111466A1 Detection method for intermolecular interaction and detection device therefor |
| 09/15/2011 | WO2011111355A1 Prophylactic/therapeutic agent for peripheral neuropathy comprising l-serine |
| 09/15/2011 | WO2011111108A1 Instrument for enzyme-linked immunoassay, and enzyme-linked immunoassay |
| 09/15/2011 | WO2011111043A1 Cellular blood markers for early diagnosis of als and for als progression |
| 09/15/2011 | WO2011111024A2 A method of magnetic resonance imaging for detecting calcium |
| 09/15/2011 | WO2011110825A1 Biosensor apparatus and use thereof |
| 09/15/2011 | WO2011110786A1 Field kit for selective detection of cocaine, crack or heroin |
| 09/15/2011 | WO2011110734A1 Apparatus for analyte sensing and associated methods |
| 09/15/2011 | WO2011110733A1 Analyte sensor and associated methods |
| 09/15/2011 | WO2011110657A1 Specific detection of human chorionic gonadotropin beta subunit type ii produced by trophoblastic and neoplastic cells |
| 09/15/2011 | WO2011110650A2 Hmgb1 and anti-hmgb1 antibodies for the prognostic of neurological disorders |
| 09/15/2011 | WO2011110565A1 Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with non-specific complaints |
| 09/15/2011 | WO2011110546A2 Pharmaceutical composition comprising an inhibitor of shp-2 and screening method |
| 09/15/2011 | WO2011110443A1 Biogas measuring device for use in a biogas plant |
| 09/15/2011 | WO2011110367A2 Method of screening for htra protease inhibitors useful for prophylaxis and therapy of a bacterial infection |
| 09/15/2011 | WO2011110359A1 Stat3 activation inhibitors |
| 09/15/2011 | WO2011110341A1 Method for determining the concentration of a peptide |
| 09/15/2011 | WO2011110192A1 A process for defining the respiration characteristics of a food product |
| 09/15/2011 | WO2011109909A1 Anti-lg3 antibodies and uses thereof |
| 09/15/2011 | WO2011109900A1 Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders |
| 09/15/2011 | WO2011109899A1 Use of tigecycline for treatment of cancer |
| 09/15/2011 | WO2011109874A1 Inhibition of glutathione transferase zeta |
| 09/15/2011 | WO2011090793A3 Multiplex microarray of serially deposited biomolecules on a microarray |
| 09/15/2011 | WO2011088524A8 Methods for regulating blood glucose levels |
| 09/15/2011 | WO2011085213A3 Pathologically-activated therapeutics |
| 09/15/2011 | WO2011065666A3 Centrifugal micro-fluidic device and method for detecting target in fluid sample |
| 09/15/2011 | WO2011063324A3 Microfluidic systems for isolating microvesicles |
| 09/15/2011 | WO2011063048A3 Urinary triaosylceramide (gb3) as a marker of cardiac disease |
| 09/15/2011 | WO2011062782A3 Innovative blood platelets biomarker for early diagnosis of alzheimer's disease |
| 09/15/2011 | WO2011057025A3 Methods and devices to enhance sensitivity and evaluate sample adequacy and reagent reactivity in rapid lateral flow immunoassays |
| 09/15/2011 | WO2011056575A3 Covalent attachment of peptides and biological molecules to luminescent semiconductor nanocrystals |
| 09/15/2011 | WO2011053971A3 Method for enhancing the sensitivity of antibody based assays |
| 09/15/2011 | WO2011052910A3 Kit for centrifugal separation, and centrifugal separation method using same |
| 09/15/2011 | WO2011050052A3 Protein agent for diabetes treatment and beta cell imaging |
| 09/15/2011 | WO2011046309A3 A diagnostic marker for hepatocellular carcinoma comprising anti-fasn autoantibodies and a diagnostic composition for hepatocellular carcinoma comprising antigens thereof |
| 09/15/2011 | WO2011040718A3 Nanofiber membrane for western blot and preparation method thereof |
| 09/15/2011 | WO2011032584A3 Method for sample identification in a mammal as well as a kit for performing this method |
| 09/15/2011 | US20110224417 Novel mixtures for assaying nucleic acid, novel method of assaying nucleic acid with the use of the same and nucleic acid probe to be used therefore |
| 09/15/2011 | US20110224415 Human muty |
| 09/15/2011 | US20110224406 Interleukin-9 receptor mutants |
| 09/15/2011 | US20110224313 Compositions and methods for classifying lung cancer and prognosing lung cancer survival |
| 09/15/2011 | US20110224243 FZD2 Molulators in the Treatment of Alopecia |
| 09/15/2011 | US20110224227 Hematopoietic protection against chemotherapeutic compounds using selective cyclin-dependent kinase 4/6 inhibitors |
| 09/15/2011 | US20110224159 Bidesmosidic betulin and betulinic acid derivatives and uses thereof as antitumor agents |
| 09/15/2011 | US20110224153 Asthma Associated Factors as Targets for Treating Atopic Allergies Including Asthma and Related Disorders |
| 09/15/2011 | US20110224144 Compositions and methods for diagnosing and treating mental disorders |
| 09/15/2011 | US20110224102 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 09/15/2011 | US20110224101 Tumor associated proteome and peptidome analyses for multiclass cancer discrimination |
| 09/15/2011 | US20110224099 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 09/15/2011 | US20110224096 Fluorescent phosphonic ester library |
| 09/15/2011 | US20110224095 Expression of functional human olfactory cyclic nucleotide gated (CNG) channel in recombinant host cells and use thereof in cell based assays to identify smell modulators |
| 09/15/2011 | US20110224092 Method and apparatus for combined electrochemical synthesis and detection of analytes |
| 09/15/2011 | US20110224091 Method and device for detecting cellular targets in bodily sources using carbon nanotube thin film |
| 09/15/2011 | US20110224090 SINGLE NUCLEOTIDE POLYMORPHIC MARKERS OF TGFBetaRIII GENE FOR DIAGONISIS OF HEPATOCELLULAR CARCINOMA |
| 09/15/2011 | US20110224088 Biomarkers for subtypes of cervical cancer |
| 09/15/2011 | US20110223691 Resonant magnetic disks for bioanalyte detection |
| 09/15/2011 | US20110223690 Assay |
| 09/15/2011 | US20110223689 Apparatus and associated methods |
| 09/15/2011 | US20110223688 Grating-based evanescent field molecular sensor using a thin silicon waveguide layer |
| 09/15/2011 | US20110223687 Method for diagnosing non-small cell lung cancer |
| 09/15/2011 | US20110223686 Protein production method, fusion protein, and antiserum |
| 09/15/2011 | US20110223685 Oxidized apoa1 determination by mass spectrometry |
| 09/15/2011 | US20110223684 Detection of specific nitrated markers |
| 09/15/2011 | US20110223683 Affinity selector based recognition and quantification system and method for multiple analytes in a single analysis |
| 09/15/2011 | US20110223682 Sample analyzer and reagent management method |
| 09/15/2011 | US20110223681 Mobile water analysis arrangement and method for determining an analyte in a water sample |
| 09/15/2011 | US20110223677 Carboxamide-substituted dyes for analytical applications |
| 09/15/2011 | US20110223676 Dna-based molecular switches and uses thereof |
| 09/15/2011 | US20110223675 Drug release means from liposomes and method for evaluating releasability |
| 09/15/2011 | US20110223672 Integrated methods for corrosivity, ageing and fingerprinting determination, as well as diagnosis, decontamination, depolarisation and detoxification of oils |
| 09/15/2011 | US20110223652 Piezoelectric-based nanopore device for the active control of the motion of polymers through the same |
| 09/15/2011 | US20110223628 METHOD FOR THE IDENTIFICATION OF A RISK FOR A THROMBOGENIC DISORDER BY DETERMINING THE TAFl-lle347 POLYMORPHISM |
| 09/15/2011 | US20110223627 Microfluidic flow assay for measuring hemostatic phenotypes |
| 09/15/2011 | US20110223624 Immunoassay for detection of neurotoxic amino acid associated with neurological disorders |
| 09/15/2011 | US20110223623 Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients |
| 09/15/2011 | US20110223622 Methods and Kits for Predicting the Onset of Labour |
| 09/15/2011 | US20110223621 Combinations for the treatment of immunoinflammatory disorders |
| 09/15/2011 | US20110223620 Method of detecting microorganisms and microorganism detecting apparatus |
| 09/15/2011 | US20110223619 Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents, and methods of use |
| 09/15/2011 | US20110223618 Assays using chimeric t1r polypeptide |
| 09/15/2011 | US20110223617 Immunoassays for autoantibodies in cardiovascular diseases |
| 09/15/2011 | US20110223616 HuR-Associated Biomarkers |
| 09/15/2011 | US20110223615 Rapid Expression Cloning of Human Monoclonal Antibodies from Memory B Cells |
| 09/15/2011 | US20110223614 Toxin detection method |
| 09/15/2011 | US20110223612 Magnetic Sensor Based Quantitative Binding Kinetics Analysis |
| 09/15/2011 | US20110223611 Lenalidomide and thalidomide immunoassays |
| 09/15/2011 | US20110223607 Circulating microrna as a marker for hepatocellular carcinoma |
| 09/15/2011 | US20110223597 Methods relating to olanzapine pharmacogenetics |
| 09/15/2011 | US20110223412 Nanowire Structural Element |
| 09/15/2011 | US20110223226 Shelf stable capsules |
| 09/15/2011 | US20110223181 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |